The present invention relates to the treatment of microbiome dysregulations. Said dysregulations may subsequently contribute to the development of […]
The present invention relates to the treatment of autoimmune diseases. The inventors determined that the cathelicidin related antimicrobial peptide […]
Worldwide, 1% to 2% of the general adult population have heart failure (HF), which is accompanied by reduced quality of life, high morbidity, […]
The present invention relates to methods of enhancing the potency of incretin-based drugs in subjects in need thereof. Through different animal […]